Recent Updates
Recently added Catalysts
ICAD

iCAD to Report Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results on Monday, March 18

Key Takeaway: NASHUA, N.H., March 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and fiscal year ended December

Full Press Release Details

NASHUA, N.H., March 13, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2018, after the close of the market and host a conference call at 4:30pm Eastern Time on Monday, March 18.
Monday, March 18, 2019, at 4:30 PM ET
Domestic: 877-407-0784
International: 201-689-8560
Conference ID: 13687103
Webcast: http://public.viavid.com/index.php?id=133091
Replays available through April 1 st :
Domestic: 844-512-2921
International: 412-317-6671
Replay PIN: 13687103
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
ARPR, on behalf of iCAD, Inc.
Last updated: Mar 13, 2019